The Gut Microbiome and Atrial Arrhythmias: A Narrative Review of Emerging Mechanisms
DOI:
https://doi.org/10.14288/hfjc.v18i1.864Keywords:
Electrophysiology, Arrythmia, Atrial Arrythmia, Systemic Inflammation, Autonomic Regulation, Microbial Metabolites, Gut-Heart Axis, Dysbiosis, SCFAs, TMAOAbstract
Background: The gut microbiome is increasingly recognized as a key modulator of systemic physiology, including inflammation, metabolism, and autonomic function, all of which are factors implicated in the development of cardiac arrhythmias. Despite this, its specific role in arrhythmogenesis, particularly atrial arrhythmias, remains underexplored. Purpose: This narrative review aims to provide an update on current information about how the gut microbiome may influence cardiac electrophysiology and contribute to the onset of atrial arrhythmias, with a focus on proposed mechanisms and call for further research into potential therapeutic interventions. Methods: Given the emerging nature of this topic and the limited consolidated literature, a narrative review approach was adopted. Sources were identified through targeted database searches using key terms such as gut microbiome, cardiac arrhythmias, atrial arrhythmias, inflammation, and autonomic nervous system. Articles were selected based on relevance and contribution to foundational or novel insights within the field. Results: Key mechanisms that need to be further researched linking the gut microbiome to arrhythmogenesis include systemic inflammation, microbial metabolite production and modulation of the autonomic nervous system. Dysbiosis contributes to an altered gut microbiome environment, allowing inflammatory mediators to affect cardiac function and disrupt electrical signaling. Conclusions: The gut microbiome appears to play a contributory role in arrhythmogenesis through pathways involving inflammation, metabolism, and autonomic regulation. While evidence continues to emerge, further research is needed to clarify the nature of this relationship and establish its relevance to atrial arrhythmia development.
Downloads
References
Al-Obaide, M., Singh, R., Datta, P., Rewers-Felkins, K., Salguero, M., Al-Obaidi, I., Rao Kottapalli, K., & Vasylyeva, T. (2017). Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD. Journal of Clinical Medicine, 6(9). https://doi.org/10.3390/jcm6090086
Antzelevitch, C., & Burashnikov, A. (2011). Overview of basic mechanisms of cardiac arrhythmia. Cardiac Electrophysiology Clinics, 3(1), 23–45. https://doi.org/10.1016/j.ccep.2010.10.012
AR Hadi, H., Alsheikh-Ali, A., Al Mahmeed, W., & Al Suwaidi, J. (2010). Inflammatory cytokines and atrial fibrillation: Current and prospective views. Journal of Inflammation Research, 75–97. https://doi.org/10.2147/JIR.S10095
Aune, D., Yahya Mahamat-Saleh, Kobeissi, E., Feng, T., Heath, A., & Janszky, I. (2023). Blood pressure, hypertension and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. European Journal of Epidemiology, 38(2), 145–178. https://doi.org/10.1007/s10654-022-00914-0
Aziz, T., Hussain, N., Hameed, Z., & Lin, L. (2024). Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: Recent challenges and future recommendations. Gut Microbes, 16(1). https://doi.org/10.1080/19490976.2023.2297864
Bhattacharyya, S., & Munshi, N. (2020). Development of the cardiac conduction system. Cold Spring Harbor Perspectives in Biology, 12(12). https://doi.org/10.1101/cshperspect.a037408
Bi, X., Zhang, S., Jiang, H., Ma, W., Li, Y., Lu, W., Yang, F., & Wei, Z. (2022). Mechanistic insights into inflammation-induced arrhythmias: A simulation study. Frontiers in Physiology, 13. https://doi.org/10.3389/fphys.2022.843292
Bruning, J., Chapp, A., Kaurala, G., Wang, R., Techtmann, S., & Chen, Q.-H. (2019). Gut microbiota and short chain fatty acids: Influence on the autonomic nervous system. Neuroscience Bulletin, 36(1), 91–95. https://doi.org/10.1007/s12264-019-00410-8
Chen, X., Bing, Z., He, J., Jiang, L., Luo, X., Su, Y., Kan, B., Huang, D., & Wei, Y. (2009). Downregulation of peroxisome proliferator-activated receptor-γ expression in hypertensive atrial fibrillation. Clinical Cardiology, 32(6), 337–345. https://doi.org/10.1002/clc.20566
Da Cruz, B., Coutinho-Wolino, K., Cardozo, L., D’Avila Pereira, A., Tinoco Mesquita, C., Stenvinkel, P., Bergman, P., Mafra, D., & Stockler-Pinto, M. (2024). Is trimethylamine N-oxide (TMAO) associated with NF-κB mRNA expression in patients with coronary artery disease? International Journal of Cardiovascular Sciences. https://doi.org/10.36660/ijcs.20230113
Dai, H., Zhang, Q., Much, A. A., Maor, E., Segev, A., Beinart, R., Adawi, S., Lu, Y., Bragazzi, N., & Wu, J. (2021). Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: Results from the Global Burden of Disease Study 2017. European Heart Journal - Quality of Care & Clinical Outcomes, 7(6), 574–582. https://doi.org/10.1093/ehjqcco/qcaa061
Di Vincenzo, F., Del Gaudio, A., Petito, V., Riccardo Lopetuso, L., & Scaldaferri, F. (2023). Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review. Internal and Emergency Medicine, 19(2), 275–293. https://doi.org/10.1007/s11739-023-03374-w
Eryd, S., Ostling, G., Rosvall, M., Persson, M., Smith, J. G., Melander, O., Bedblad, B., & Engstrom, G. (2014). Carotid intima-media thickness is associated with incidence of hospitalized atrial fibrillation. Atherosclerosis, 233(2), 673–678. https://doi.org/10.1016/j.atherosclerosis.2014.01.050
Fan, H., Liu, X., Ren, Z., Fei, X., Luo, J., Yang, X., Xue, Y., Zhang, F., & Liang, B. (2023). Gut microbiota and cardiac arrhythmia. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1147687
Fedele, L., & Brand, T. (2020). The intrinsic cardiac nervous system and its role in cardiac pacemaking and conduction. Journal of Cardiovascular Development and Disease, 7(4). https://doi.org/10.3390/jcdd7040054
Gatarek, P., & Kaluzna-Czaplinska, J. (2021). Trimethylamine N-oxide (TMAO) in human health. Experimental and Clinical Sciences, 20, 301–319. https://doi.org/10.17179/excli2020-3239
Gawalko, M., Agbaedeng, T., Saljic, A., Muller, D., Wilck, N., Schnabel, R., Penders, J., Rienstra, M., van Gelder, I., Jespersen, T., Schotten, U., Crijns, H., Kalman, J., Sanders, P., Nattel, S., Dobrev, D., & Linz, D. (2021). Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovascular Research, 118(11), 2415–2427. https://doi.org/10.1093/cvr/cvab292
Guinane, C., & Cotter, P. (2013). Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology, 6(4), 295–308. https://doi.org/10.1177/1756283X13482996
Guo, Y., Lip, G., & Apostolakis, S. (2012). Inflammation in atrial fibrillation. JACC, 60(22), 2263–2270. https://doi.org/10.1016/j.jacc.2012.04.063
Heeringa, J., van der Kuip, D., Hofman, A., Kors, J., van rooij, F., Lip, G., & Witteman, J. (2007). Subclinical atherosclerosis and risk of atrial fibrillation The Rotterdam Study. JAMA Internal Medicine, 167(4), 382–387. https://doi.org/10.1001/archinte.167.4.382
Huang, R., Yan, L., & Lei, Y. (2021). The Gut Microbial-derived metabolite trimethylamine N-Oxide and atrial fibrillation: Relationships, mechanisms, and therapeutic strategies. Clinical Interventions in Aging, 16, 1975–1986. https://doi.org/10.2147/CIA.S339590
Khurshid, S., Choi, S. H., Weng, L.-C., Wang, Y., Trinquart, L., Benjamin, E., Ellinor, P., & Lubitz, S. (2018). Frequency of cardiac rhythm abnormalities in a half million adults. Circulation: Arrhythmia and Electrophysiology, 11(7). https://doi.org/10.1161/CIRCEP.118.006273
Kornej, J., Borschel, C., Benjamin, E., & Schnabel, R. (2020). Epidemiology of atrial fibrillation in the 21st Century: Novel methods and new insights. Circulation Research, 127(1). https://doi.org/10.1161/CIRCRESAHA.120.316340
Martinez, J., Kahana, D., Ghuman, S., Wilson, H., Wilson, J., Kim, S., Lagishetty, V., Jacobs, J., Sinha-Hikim, A., & Friedman, T. (2021). Unhealthy lifestyle and gut dysbiosis: A better understanding of the effects of poor diet and nicotine on the intestinal microbiome. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.667066
Nogal, A., Valdes, A., & Menni, C. (2021). The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes, 13(1). https://doi.org/10.1080/19490976.2021.1897212
Oakly, C., Vallejo, J., Wang, D., Gray, M., Tiede-Lewis, L., Shawgo, T., Daon, E., Zorn, G., Stubbs, J., & Wacker, M. (2020). Trimethylamine-N-oxide acutely increases cardiac muscle contractility. American Journal of Physiology Heart and Circulatory Physiology, 318(5), 1272–1282. https://doi.org/10.1152/ajpheart.00507.2019
Pai, U., Prabhu, M., Devasia, T., Rao, S., V, R., Samanth, J., Prabhu, S., Lolita Mathias, H., & V, C. (2023). Prevalence of metabolic syndrome and its association with atrial arrhythmias in patients with implanted permanent pacemaker for cardiac conduction abnormality. Indian Heart Journal, 75(6), 462–464. https://doi.org/10.1016/j.ihj.2023.10.006
Park, J, Lee, E., Lee, J, Kim, W., & Kim, H. (2007). Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells: Involvement of NF-κB and ERK signaling pathways. International Immunopharmacology, 7(1), 70–77. https://doi.org/10.1016/j.intimp.2006.08.015
Qanawah, Q., Ababneh, M., & Dagamseh, A. (2024). Cardiac arrhythmias classification using photoplethysmography database. Scientific Reports, 14. https://doi.org/10.1038/s41598-024-53142-9
Sanna, S., Kurilshikov, A., van der Graaf, A., Fu, J., & Zhernakova, A. (2022). Challenges and future directions for studying effects of host genetics on the gut microbiome. Nature Genetics, 54, 100–106. https://doi.org/10.1038/s41588-021-00983-z
Singh, P., Meenatchi, R., Ahmed, Z. H. T., Thacharodi, A., Rohinth, M., Kumar, R., Varthan M .K. H., & Hassan, S. (2024). Implications of the gut microbiome in cardiovascular diseases: Association of gut microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine. Medicine in Microecology, 19. https://doi.org/10.1016/j.medmic.2023.100096
Tabata, T., Yamashita, T., Hosomi, K., Park, J., Hayashi, T., Yoshida, N., Saito, Y., Fukuzawa, K., Konishi, K., Murakami, H., Kawashima, H., Mizuguchi, K., Miyachi, M., Kunisawa, J., & Hirata, K. (2020). Gut microbial composition in patients with atrial fibrillation: Effects of diet and drugs. Springer, 36(1), 105–114. https://doi.org/10.1007/s00380-020-01669-y
Tang, W. W., Kitai, T., & Hazen, S. (2017). Gut Microbiota in cardiovascular health and disease. Circulation Research, 120(7), 1183–1196. https://doi.org/10.1161/CIRCRESAHA.117.309715
Tao, R., de Zoeten, E., Ozkaynak, E., Chen, C., Wang, L., Porrett, P., Li, B., Turka, L., Olson, E., Greene, M., Wells, A., & Hancock, W. (2007). Deacetylase inhibition promotes the generation and function of regulatory T cells. Nature Medicine, 13, 1299–1307. https://doi.org/10.1038/nm1652
Thursby, E., & Juge, N. (2017). Introduction to the human gut microbiota. Biochemical Journal, 474(11), 1823–1836. https://doi.org/10.1042/BCJ20160510
Vinolo, M., Rodrigues, H., Nachbar, R., & Curi, R. (2011). Regulation of inflammation by short chain fatty acids. Nutrients, 3(10), 858–876. https://doi.org/10.3390/nu3100858
Waldmann, V., Jouven, X., Narayanan, K., Piot, O., Chugh, S., Albert, C., & Marijon, E. (2020). Association between atrial fibrillation and sudden cardiac death: Pathophysiological and epidemiological insights. Circulation Research, 127(2). https://doi.org/10.1161/CIRCRESAHA.120.316756
Willeit, K., Pechlaner, R., Egger, G., Weger, S., Oberhollenzer, M., Willeit, J., & Kiechl, S. (2013). Carotid atherosclerosis and incident atrial fibrillation. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(11). https://doi.org/10.1161/ATVBAHA.113.302272
Willeit, K., & Kiechl, S. (2024). Atherosclerosis and atrial fibrillation – Two closely intertwined diseases. Atherosclerosis, 233(2), 679–681. https://doi.org/10.1016/j.atherosclerosis.2013.11.082
Wu, H., & Chiou, J. (2021). Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients, 13(8). https://doi.org/10.3390/nu13082878
Yang, X., Zhao, S., Wang, S., Cao, X., Xu, Y., Yan, M., Pang, M., Yi, F., & Wang, H. (2023). Systemic inflammation indicators and risk of incident arrhythmias in 478,524 individuals: Evidence from the UK Biobank cohort. BMC Medicine, 21. https://doi.org/10.1186/s12916-023-02770-5
Yang, Z., Wang, Q., Liu, Y., Wang, L., Ge, Z., & Zhenzhen, L. (2023). Gut microbiota and hypertension: Association, mechanisms and treatment. Clinical and Experimental Hypertension, 45(1). https://doi.org/10.1080/10641963.2023.2195135
Yukino-Iwashita, M., Nagatomo, Y., Kawai, A., Taruoka, A., Yumita, Y., Kagami, K., Yasuda, R., Toya, T., Ikegami, Y., Masaki, N., Ido, Y., & Adachi, T. (2022). Short-chain fatty acids in gut–heart axis: Their role in the pathology of heart failure. Personalized Medicine, 12(11). https://doi.org/10.3390/jpm12111805
Zhang, Y., Wang, Y., Ke, B., & Du, J. (2021). TMAO: How gut microbiota contributes to heart failure. Translational Research, 228, 109–125. https://doi.org/10.1016/j.trsl.2020.08.007
Zhu, W., Gregory, J., Org, E., Buffa, J., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., Sartor, R. B., Mcintyre, T., Silverstein, R., Tang, W. W., DiDonato, J., Brown, M., Lusis, A., & Hazen, S. (2016). Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell Press, 165(1), 111–124. https://doi.org/10.1016/j.cell.2016.02.011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nicholas Burton
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Terms of Publication
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the Health & Fitness Journal of Canada’s right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- The Contributor (author(s)) represents and guarantees that the Contributor is the sole proprietor of the work and the Contributor has full power to make this Agreement and grant that the work does not infringe the copyright or other proprietary right of any other person; and the work contains no libellous or other unlawful matter and makes no improper invasion of the privacy of any other person. The Contributor also represents and is responsible for the accuracy of the work.
- The Contributor will read, correct, and return promptly galleys and page proofs to the Editor (or designate). The Contributor will be responsible for the completeness and accuracy of these corrections. If the Contributor does not return galleys and page proofs within the schedule agreed upon with the Editor (or designate), the Publisher may proceed without the Contributor corrections.
- When applicable, the Contributor agrees to obtain written permissions and letters of agreement for all matter contained in the work that is protected by existing copyright, paying any permission fees for the use of text or illustrations controlled by others, and furnishing the Publisher with written evidence of the copyright owner’s authorization to use the material.
- When applicable, the Contributor agrees to obtain written permission for inclusion of any photographic materials involving a human subject, and provide the Publisher with written evidence of the subject’s authorization to use this material. In the case of subjects who have not reached the age of majority, the Contributor agrees to obtain and furnish the Publisher with written permission from the parent and/or legal guardian.
- The Contributor may draw on and refer to material in the work in preparing other articles for publication in scholarly and professional journals and papers for delivery at professional meetings, provided that credit is given to the work and to the Publisher.
- This agreement may not be changed unless the Contributor and the Publisher agree to the change by means of a formal addendum signed by the Contributor and the Publisher’s representative.
- This agreement shall be construed and governed according to the laws of the province of British Columbia and shall be binding upon the parties hereto, their heirs, successors, assigns, and personal representatives. Should any formal proceedings related to this agreement be brought, such formal proceeding may be brought only in the province of British Columbia.
By submitting an article to the Health & Fitness Journal of Canada the Contributor has accepted and agreed to all terms outlined in the copyright notice.
